Selective tumor cell targeting by the disaccharide moiety of bleomycin.
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
复制标题
DOI:
10.1021/ja311090e
复制
发表时间:
2013-02-27
影响因子:
15
通讯作者:
Hecht, Sidney M.
中科院分区:
文献类型:
--
作者:
Yu, Zhiqiang;Schmaltz, Ryan M.;Bozeman, Trevor C.;Paul, Rakesh;Rishel, Michael J.;Tsosie, Krystal S.;Hecht, Sidney M.
In a recent study, the well documented tumor targeting properties of the antitumor agent bleomycin (BLM) were studied in cell culture using microbubbles that had been derivatized with multiple copies of BLM. It was shown that BLM selectively targeted MCF-7 human breast carcinoma cells, but not the “normal” breast cell line MCF-10A. Further, the BLM analogue deglycobleomycin, which lacks the disaccharide moiety of BLM, was found not to target either cell line, indicating that the BLM disaccharide moiety is necessary for tumor selectivity. Not resolved in the earlier study was the issue of whether the BLM disaccharide moiety alone is sufficient for tumor cell targeting, as well as the possible cellular uptake of the disaccharide. In the present study, we have conjugated BLM, deglycoBLM and BLM disaccharide to the cyanine dye Cy5**. It was found that the BLM and BLM disaccharide conjugates, but not the deglycoBLM conjugate, bound selectively to MCF-7 cells, and were internalized. The same was also true for the prostate cancer cell line DU-145 (but not for normal PZ-HPV-7 prostate cells) and for the pancreas cancer cell line BxPC-3 (but not for normal SVR A221a pancreas cells). The targeting efficiency of the disaccharide was only slightly less than that of BLM in MCF-7 and DU-145 cells, and comparable to BLM in BxPC-3 cells. These results establish that the BLM disaccharide is both necessary and sufficient for tumor cell targeting, a finding with obvious implications for the design of novel tumor imaging and therapeutic agents.
登录
查看更多内容
影响因子:
19.7
作者:
BEKERMAN, C;MORAN, EM;GOTTSCHALK, A
通讯作者:
GOTTSCHALK, A
DOI:
10.1002/mpo.2950010104
发表时间:
1975-01-01
期刊:
Medical and Pediatric Oncology
影响因子:
--
作者:
JONES S E;LILIEN D L;SALMON S E
通讯作者:
SALMON S E
影响因子:
2.9
作者:
HOLMES, CE;CARTER, BJ;HECHT, SM
通讯作者:
HECHT, SM
影响因子:
15
作者:
Tao, Zhi-Fu;Konishi, Kazuhide;Hecht, Sidney M.
通讯作者:
Hecht, Sidney M.
影响因子:
15
作者:
Chapuis JC;Schmaltz RM;Tsosie KS;Belohlavek M;Hecht SM
通讯作者:
Hecht SM